Media & Press relations

Our latest press releases

December 22, 2025

WellStreet Urgent Care, bioMérieux celebrate 200,000 patients served through BIOFIRE® SPOTFIRE® tests in urgent care clinics across Georgia, Ohio and South Carolina

WellStreet Urgent Care and bioMérieux announce the 200,000th patient diagnosed via the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini in their urgent clinics since the first instrument placement in February 2025.

Discover more

Swipe for more

December 04, 2025

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of its immunoassay endocrinology offer for equine health, consisting of VIDAS® Equine INSULIN and VIDAS® Equine ACTH.

Read more
December 01, 2025

bioMérieux Honored with Multiple 2025 IMV ServiceTrak™ Clinical Laboratory Awards for Diagnostic Excellence

bioMérieux received nine 2025 IMV ServiceTrak™ Clinical Laboratory Awards for excellence in Immunoassay Analyzers, ID/AST Systems, Molecular Diagnostics and Blood Culture Systems.

Read more
November 05, 2025

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

Oxford Nanopore Technologies and bioMérieux have announced the launch of AmPORE-TB, a Research Use Only (RUO) solution for the rapid characterization of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore sequencing technology.

Read more